Drug intelligence / Profile preview

Yanlu Rukang

Development stage
Unknown
Lead developer
Yunnan Runhai Medical Investment
Modality
Small Molecules
Administration
Oral
01

Overview

Yanlu Rukang is a traditional Chinese medicine (TCM) formulation primarily indicated for the treatment of mammary gland hyperplasia (also known as cyclomastopathy or benign breast hyperplasia). It is available in capsule form and is recognized under the approval number Z20025379 in China. The preparation contains multiple herbal ingredients, with bergenin being one of the notable components. The mechanism of action is not fully elucidated but is believed to involve modulation of endocrine function and anti-inflammatory effects typical of TCM approaches to benign breast disorders. There are also reports suggesting its use in other conditions such as Peyronie's disease (induration of penis), though its primary indication remains mammary gland hyperplasia[1][2][6].

Brand names
Yanlu Rukang
Other names
Yan Lu Ru Kang CapsuleYLRKC

Beyond the preview

Go deeper on Yanlu Rukang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yanlu Rukang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call